日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

From "when to stop" to "why continue today?": operationalizing RRT weaning with UUEI

从“何时停止”到“今天为何继续?”:利用UUEI实施RRT撤机

Orieux, Arthur; Bodot, Simon; Gisbert-Mora, Chloé; Boyer, Alexandre

Effects of the urinary urea excretion index on the decision to wean ICU patients with acute kidney injury from renal replacement therapy: a before-after multicentre study (D-STOP)

尿素排泄指数对急性肾损伤ICU患者脱离肾脏替代治疗决策的影响:一项前后多中心研究(D-STOP)

Bodot, Simon; Gros, Alexandre; Le Gall, Lisa; Martin, Aurélie; Gisbert-Mora, Chloé; Pillot, Jerome; Ragot, Claire; Grand, Hubert; Romen, Antoine; Masri, Alexandre; Dewitte, Antoine; Gruson, Didier; Prevel, Renaud; Rubin, Sebastien; Orieux, Arthur; Boyer, Alexandre

Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50

更正:真实世界多中心队列研究,评估一线帕博利珠单抗单药或联合铂类化疗治疗PD-L1≥50的非小细胞肺癌的效果

Pons-Tostivint, E; Hulo, P; Guardiolle, V; Bodot, L; Rabeau, A; Porte, M; Hiret, S; Demontrond, P; Curcio, H; Boudoussier, A; Veillon, R; Mayenga, M; Dumenil, C; Chatellier, T; Gourraud, P A; Mazieres, J; Bennouna, J

Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50

一项真实世界多中心队列研究,评估帕博利珠单抗单药或联合铂类化疗一线治疗PD-L1≥50的非小细胞肺癌的疗效。

Pons-Tostivint, E; Hulo, P; Guardiolle, V; Bodot, L; Rabeau, A; Porte, M; Hiret, S; Demontrond, P; Curcio, H; Boudoussier, A; Veillon, R; Mayenga, M; Dumenil, C; Chatellier, T; Gourraud, P A; Mazieres, J; Bennouna, J

Association Between Alcohol Consumption and Nocturnal Leg Cramps in Patients Over 60 Years Old: A Case-Control Study

饮酒与60岁以上患者夜间腿抽筋的关联:一项病例对照研究

Delacour, Chloé; Chambe, Juliette; Lefebvre, François; Bodot, Claire; Bigerel, Elodie; Epifani, Laetitia; Granda, Céline; Haller, Dagmar M; Maisonneuve, Hubert